Blue Jet Healthcare shares tumble 10% after JPMorgan downgrade, 17% downside seen

The downgrade is driven by multiple concerns, including weak execution in the contrast media business, which has declined due to muted performance in its flagship product and a lack of meaningful new launches.

Leave a Reply

Your email address will not be published. Required fields are marked *